DD201900A5 - Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen - Google Patents

Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen Download PDF

Info

Publication number
DD201900A5
DD201900A5 DD81234718A DD23471881A DD201900A5 DD 201900 A5 DD201900 A5 DD 201900A5 DD 81234718 A DD81234718 A DD 81234718A DD 23471881 A DD23471881 A DD 23471881A DD 201900 A5 DD201900 A5 DD 201900A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
radical
chain
aryl
bis
Prior art date
Application number
DD81234718A
Other languages
German (de)
English (en)
Inventor
Siegfried Goldmann
Andreas Knorr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DD201900A5 publication Critical patent/DD201900A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD81234718A 1980-11-13 1981-11-09 Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen DD201900A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042769 DE3042769A1 (de) 1980-11-13 1980-11-13 C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD201900A5 true DD201900A5 (de) 1983-08-17

Family

ID=6116648

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81234718A DD201900A5 (de) 1980-11-13 1981-11-09 Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen

Country Status (16)

Country Link
EP (1) EP0052300B1 (fr)
JP (1) JPS57109766A (fr)
AT (1) ATE11773T1 (fr)
AU (1) AU546605B2 (fr)
CA (1) CA1179342A (fr)
DD (1) DD201900A5 (fr)
DE (2) DE3042769A1 (fr)
DK (1) DK501881A (fr)
ES (3) ES8206477A1 (fr)
FI (1) FI813567L (fr)
GR (1) GR76338B (fr)
HU (1) HU186438B (fr)
IL (1) IL64253A (fr)
NO (1) NO813649L (fr)
PT (1) PT73920B (fr)
ZA (1) ZA817840B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0145956A1 (fr) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Amide compounds
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
IT1203900B (it) * 1987-04-15 1989-02-23 Lagor Spa Poli 1,4-diidro-2,6-dimetilpiridine 3,5-dicarbossilesteri utili come stabilizzanti termici per polimeri sintetici
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
EP1085863A1 (fr) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Nouveaux medicaments pour traiter les etats dus aux canaux calcium et leurs utilisations
US6897305B2 (en) 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
US7101909B2 (en) 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795791A1 (de) * 1966-11-16 1975-06-19 Astra Ab Pyridinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ES507080A0 (es) 1982-08-16
ATE11773T1 (de) 1985-02-15
FI813567A7 (fi) 1982-05-14
ES8303337A1 (es) 1983-02-01
AU7711081A (en) 1982-05-20
HU186438B (en) 1985-07-29
JPS57109766A (en) 1982-07-08
DE3042769A1 (de) 1982-06-09
NO813649L (no) 1982-05-14
PT73920B (en) 1983-03-29
FI813567L (fi) 1982-05-14
ES510253A0 (es) 1983-02-01
IL64253A (en) 1985-03-31
PT73920A (en) 1981-12-01
DK501881A (da) 1982-05-14
ES8303336A1 (es) 1983-02-01
ZA817840B (en) 1982-10-27
IL64253A0 (en) 1982-02-28
AU546605B2 (en) 1985-09-12
ES510254A0 (es) 1983-02-01
CA1179342A (fr) 1984-12-11
DE3168955D1 (en) 1985-03-28
ES8206477A1 (es) 1982-08-16
GR76338B (fr) 1984-08-04
EP0052300A1 (fr) 1982-05-26
EP0052300B1 (fr) 1985-02-13

Similar Documents

Publication Publication Date Title
EP0012180B1 (fr) Composés de la 1,4-dihydropyridine, procédé pour leur préparation, compositions pharmaceutiques contenant lesdits composés et procédé pour la production de ces compositions
EP0088274B1 (fr) 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments
EP0088276B1 (fr) Composés, leurs procédés de préparation et leur application comme médicaments
EP0002208B1 (fr) Nitro dihydro-1,4 pyridines, médicaments les contenant et leur procédé de préparation
EP0071819B2 (fr) Dihydropyridines, douées d'une activité inotrope positive, leur application comme médicaments, et leurs procédés de préparation
EP0011706B1 (fr) Procédé pour la préparation de dérivés de l'acide 1,4-dihydropyridine-3-carboxylique, dérivés de l'acide 1,4-dihydropyridine-3-carboxylique et utilisation de ces dérivés pour la préparation de 1,4-dihydropyridine-3,5-dicarboxylates
DE2935451A1 (de) Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DD201900A5 (de) Verfahren zur herstellung von c-3 verknuepften 1,4-dihydropyridinen
EP0009206A2 (fr) 1,4-Dihydropyridines fluorées, médicaments les contenant et procédé pour leur préparation
EP0001769A1 (fr) Esters contenant du soufre d'acides dihydro-1,4-pyridine carboxyliques, leur préparation et leur application comme médicaments
EP0039863B1 (fr) Dihydro-1,4 pyridines comportant des substituants différents en positions 2 et 6, procédés pour leur préparation et leur utilisation dans des médicaments
CH634053A5 (de) Verfahren zur herstellung neuer aminoalkylidenamino-1.4-dihydropyridine.
DE2658804A1 (de) Kreislaufbeeinflussende mittel
EP0110259A1 (fr) 1,4-Dihydropyridines, leurs procédés de préparation ainsi que leur application comme médicaments
DE2837477A1 (de) Sila-substituierte 1,4-dihydropyridin- derivate
DE2549568C3 (de) 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2847237A1 (de) Verfahren zur herstellung von 1,4-dihydropyridincarbonsaeuren sowie ihre verwendung als arzneimittel
CH633265A5 (de) Verfahren zur herstellung des neuen 1.4-dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsaeure-isopropyl-(2-propoxy-aethyl)-esters.
DE2639498A1 (de) Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616991A1 (de) Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0167068B1 (fr) Ester isopropyle-[2-(3-trifluorométhylphénoxy)éthyl] de l'acide 1,4-dihydro-2,6-diméthyl-4-(3-nitrophényl)-pyridine-3,5-dicarboxylique, ses procédés de préparation et son application comme médicament
DE3501855A1 (de) 5-aryl-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0225574A1 (fr) Dihydro-1,4 pyridines fluorées, procédé pour leur préparation et leur application comme médicaments
DE3023821A1 (de) 4,4-disubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0199238A1 (fr) Dérivés de la dihydro-1,4 pyridine, leur procédé de préparation et leur utilisation dans des médicaments